China National Accord Medicines (SZSE:000028) Total Stockholders Equity : ¥17,804 Mil (As of Mar. 2024)

View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Total Stockholders Equity?

China National Accord Medicines's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥17,804 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. China National Accord Medicines's Book Value per Share for the quarter that ended in Mar. 2024 was ¥31.99. The ratio of a company's debt over equity can be used to measure how leveraged this company is. China National Accord Medicines's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.37.

China National Accord Medicines Total Stockholders Equity Historical Data

The historical data trend for China National Accord Medicines's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Total Stockholders Equity Chart

China National Accord Medicines Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

12,911.14

13,948.32

14,924.94

16,125.89

17,414.81

China National Accord Medicines Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															16,488.09	16,613.53	16,972.95	17,414.81	17,803.58

China National Accord Medicines (SZSE:000028) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

China National Accord Medicines's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(17803.579	-	0)	/	556.565
	=	31.99

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

China National Accord Medicines's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(4867.44	+	1642.184)	/	17803.579
	=	0.37

China National Accord Medicines Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

China National Accord Medicines (SZSE:000028) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

200028:China

Address

No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029

Website

http://www.szaccord.com.cn

China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines